Taiwan Advance Bio-Pharmaceutical Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Advance Bio-Pharmaceutical Inc with three other
companies in this sector in Taiwan:
Handa Pharmaceuticals Inc
sales of 93.69 million Taiwanese Dollars [US$3.07 million]
of which 100%
was New Medicine Development),
Naturewise Biotech & Medicals Corporation
(108.48 million Taiwanese Dollars [US$3.56 million]
Holy Stone Healthcare Co Ltd
(172.84 million Taiwanese Dollars [US$5.67 million]
During the year ended December of 2018, sales at
Taiwan Advance Bio-Pharmaceutical Inc were 168.35 million Taiwanese Dollars (US$5.52 million).
increase of 16.1%
versus 2017, when the company's sales were 145.06 million Taiwanese Dollars.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Taiwan Advance Bio-Pharmaceutical Inc had sales
of 163.49 million Taiwanese Dollars.